It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2007.
2007 | Hyderabad, Telangana, India | ActiveVaishno Drugs & Intermediates Private Limited, a active private limited company, was established on 06 November 2007 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2007PTC056229. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Venkateswara Reddy Bommareddy (Managing Director), Sitaravamma Bommareddy (Director). Past directors included Venkateswara Reddy Bommareddy. It holds ₹0.70 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No.302, Sri Balaji'S Dundhumulla Heights, Sy No.210&211, Gajularamaram(V),Qutbulla, Pur(M), Hyderabad, Telangana, 500055.
U24232TG2007PTC056229
056229
06 November 2007
₹2.50 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Vaishno Drugs & Intermediates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkateswara Reddy Bommareddy | Managing Director | 06 Nov 2007 | Current |
| Sitaravamma Bommareddy | Director | 06 Nov 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Nov 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vaishno Drugs & Intermediates Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 20.26% increase. The company also saw a substantial improvement in profitability, with a 158.84% increase in profit. The company's net worth moved up by a moderate rise of 2.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Vaishno Drugs & Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹695,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2008 | Hdfc Bank Limited | ₹0.70 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vaishno Drugs & Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vaishno Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaishno Drugs & Intermediates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Vaishno Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Vaishno Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.70 M with Charge ID 10130011 was registered on 07 Nov 2008. was recorded as a recent event.
The activity Venkateswara Reddy Bommareddy was appointed as a Managing Director was appointed as a Managing Director on 06 Nov 2007 & has been associated with this company since 18 years 1 month . was completed.
Sitaravamma Bommareddy was appointed as a Director was appointed as a Director on 06 Nov 2007 & has been associated with this company since 18 years 1 month . was recorded as a recent event.
Vaishno Drugs & Intermediates Private Limited was registered on 06 Nov 2007 with Roc Hyderabad & aged 18 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Vaishno Drugs & Intermediates Private Limited is U24232TG2007PTC056229.
Vaishno Drugs & Intermediates Private Limited is headquartered at Flat No.302, Sri Balaji'S Dundhumulla Heights, Sy No.210&211, Gajularamaram(V),Qutbulla, Pur(M), Hyderabad, Telangana, 500055.
Vaishno Drugs & Intermediates Private Limited was incorporated on 06 November 2007.
The current directors of Vaishno Drugs & Intermediates Private Limited are
The primary industry of Vaishno Drugs & Intermediates Private Limited is Manufacturing.
Vaishno Drugs & Intermediates Private Limited is unlisted.
The authorized capital of Vaishno Drugs & Intermediates Private Limited is ₹2.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Vaishno Drugs & Intermediates Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX